Clin Osteol 2021; 26(3): 143-146

Fibrous dysplasiaReview articles

Raška Ivan
III. interní klinika - endokrinologie a metabolismu 1. LF UK a VFN v Praze

Fibrous dysplasia (FD) is a congenital skeletal disease characterized by the presence of bone lesions containing fibrous connective tissue. FD occurs in monoostotic or polyostotic form. Rarely, fibrous dysplasia is part of McCune-Albright syndrome together with "café au lait" cutaneous hyperpigmentations and endocrine hyperfunction (especially pubertas praecox, thyrotoxicosis, Cushing's syndrome, etc.). Clinical symptomatology depends on the extent of the bone disease. Most bone lesions in FD are asymptomatic, with a minority of bone lesions manifesting as pain, bone deformity, or pathological fracture. The following article provides a brief overview of current knowledge about fibrous dysplasia.

Keywords: bone deformity; fibrous dysplasia; McCune-Albright syndrome; pathological fracture

Published: December 11, 2021  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Raška I. Fibrous dysplasia. Clinical Osteology. 2021;26(3):143-146.
Download citation

References

  1. Boyce AM, Florenzano P, de Castro LF et al. Fibrous Dysplasia/McCune-Albright Syndrome. Gene Reviews 2015. In: GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2021.
  2. McCune DJ. Osteitis fibrosa cystica: The case of a nine-year-old girl who also exhibits precocious puberty, multiple pigmentation of the skin and hyperthyroidism. Am J Dis Child 1936; 52 : 743-744.
  3. Weinstein LS, Shenker A, Gejman PV et al. Activating mutations of the stimulatory G protein in the McCune-Albright syndrome. N Engl J Med 1 991; 3 25(24): 1 688-1695. D ostupné z DOI: < http://dx.doi.org/10.1056/NEJM199112123252403>.
  4. Kelly MH, Brillante B, Collins MT. Pain in fibrous dysplasia of bone: age-related changes and the anatomical distribution of skeletal lesions. O steoporos I nt 2 008; 1 9(1): 5 7-63. D ostupné z DOI: < http://dx.doi.org/10.1007/s00198-007-0425-x>.
  5. Cruz-Ferreira AM. Craniofacial Polyostotic Fibrous Dysplasia Initially Diagnosed in a Primary Care Unit. Korean J Fam Med 2019; 40(1): 58-60. Dostupné z DOI: <http://dx.doi.org/10.4082/kjfm.17.0129>. Go to original source...
  6. Gupta S, Jain S, Newaskar V, Ali M et al. Craniofacial fibrous dysplasia with facial asymmetry, canted occlusion and open bite: a case report with 2 years follow-up. J Contemp Dent Pract 2014; 15(5): 636-645. Dostupné z DOI: <http://dx.doi.org/10.5005/jp-journals-10024-1592>. Go to original source...
  7. Salenave S, Boyce AM, Collins M et al. Acromegaly and McCune-Albright syndrome. J Clin Endocrinol Metab 2014; 99(6): 1955-1969. <Dostupné z DOI: http://dx.doi.org/10.1210/jc.2013-3826>. Go to original source...
  8. Mahdi AJ, Connor P, Thakur I. McCune-Albright syndrome-associated bone marrow failure and extramedullary haematopoeisis secondary to fibrous dysplasia. Br J Haematol 2017; 178(2): 179. Dostupné z DOI: <http://dx.doi.org/10.1111/bjh.14690>. Go to original source...
  9. Majoor BC, Boyce AM, Bovée JV et al. Increased Risk of Breast Cancer at a Young Age in Women with Fibrous Dysplasia. J Bone Miner Res 2018; 3 3(1): 8 4-90. Dostupné z DOI: <http://dx.doi.org/10.1002/jbmr.3286>. Go to original source...
  10. Pečený J, Šťastný E, Wagenknecht L et al. Fibrózní dysplazie -⁠ patofyziologie aortopedická léčba. Pediatr Praxi 2018; 19(2): 72-78. Dostupné z DOI: <http://dx.doi.org/10.36290/ped.2018.015>. Go to original source...
  11. Kurinec F; Rudinský B; Marinčák L. Chirurgická liečba rozsiahlej fibróznej dysplázie v kraniofaciálnej oblasti -⁠ kazuistika. Cesk Slov Neurol N 2016; 79/112(6): 723-727.




Clinical Osteology

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.